Data Presentation for FDA Submissions ensures clear, accurate, and standardized reporting of clinical and regulatory data.
Data Presentation for FDA Submissions
- Effective data presentation is critical for regulatory submissions.
- The FDA requires that data be presented clearly, accurately, and in a standardized format to facilitate review.
Electronic Common Technical Document (eCTD)
- Structure: Five modules covering administrative information, summaries, quality, non-clinical, and clinical data.
- Standardization: Ensures consistency across submissions.
Advertisements
Data Standards
- CDISC (Clinical Data Interchange Standards Consortium)
- SDTM (Study Data Tabulation Model): Organizes data collected during clinical trials.
- ADaM (Analysis Data Model): Structures data for analysis.
- FDA’s Data Standards Catalog: Specifies acceptable formats.
Advertisements
Key Principles
-
Clarity
- Tables and Figures: Should be well-labeled and easy to interpret.
- Narrative Summaries: Provide context and explanations.
-
Accuracy
- Data Verification: Ensure data matches source documents.
- Consistency: Align data across different sections.
-
Completeness
- All Relevant Data: Include both positive and negative findings.
- Transparency: Disclose methodologies and limitations.
-
Compliance
- Regulatory Requirements: Adhere to FDA guidelines on data presentation.
- Good Clinical Data Management Practices
Advertisements
Common Pitfalls to Avoid
- Incomplete Datasets: Missing critical information.
- Inconsistent Data: Discrepancies between datasets.
- Poor Formatting: Non-standardized presentations hinder review.
